Advanced Anti-Wrinkle Therapy Cicatricure 3 g/100g
Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4% · CREAM · Genomma Lab
Advanced Anti-Wrinkle Therapy Cicatricure is a cream containing avobenxone 3%, octinoxate 7.5%, octisalate 5%, octocrylene 2.7%, oxybenzone 4% at 3 g/100g, taken topical. Manufactured by Genomma Lab.
Key Facts
- Brand Name
- Advanced Anti-Wrinkle Therapy Cicatricure
- Generic Name
- Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%
- NDC Code (Product)
50066-021- Manufacturer
- Genomma Lab
- Strength
- 3 g/100g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- part352
- Marketing Start
- 01/21/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Advanced Anti-Wrinkle Therapy Cicatricure used for?
Advanced Anti-Wrinkle Therapy Cicatricure contains Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%. It is a cream taken topical. Consult your doctor for specific uses.
Is Advanced Anti-Wrinkle Therapy Cicatricure a controlled substance?
Advanced Anti-Wrinkle Therapy Cicatricure is not classified as a controlled substance by the DEA.
What is the generic name for Advanced Anti-Wrinkle Therapy Cicatricure?
The generic name for Advanced Anti-Wrinkle Therapy Cicatricure is Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%. There are no other listed brand versions of Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%.
What is the NDC code for Advanced Anti-Wrinkle Therapy Cicatricure 3 g/100g?
The NDC (National Drug Code) for Advanced Anti-Wrinkle Therapy Cicatricure 3 g/100g is 50066-021, listed by Genomma Lab.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)